| Dyllan Tiburzi, | |
|
2235 Cleveland Rd, South Bend, IN 46628-3529 | |
| (574) 647-4530 | |
| (574) 647-2285 |
| Full Name | Dyllan Tiburzi |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 6 Years |
| Location | 2235 Cleveland Rd, South Bend, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326536095 | NPI | - | NPPES |
| 300014050 | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 01085663A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Memorial Hospital Of South Bend | South bend, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Beacon Medical Group Inc | 1254243306 | 452 |
News Archive
The changing tide of Alzheimer's diagnosis presents new challenges to the public, physicians and lawmakers: if you could find out your Alzheimer's risk, would you want to know? How should doctors tell you your risk? And what does it mean for the many newly diagnosed Americans still in the workplace?
Cubist Pharmaceuticals, Inc. and Adolor Corporation today announced that they have signed a definitive agreement under which Cubist will acquire all of the outstanding shares of Adolor for $4.25 per share in cash, or approximately $190 million on a fully-diluted basis, net of Adolor's third quarter 2011 cash balance.
Women with recurrent miscarriage and infertility are undergoing tests and treatments that have no scientific rationale and are linked with known risks to mother and fetus, warn researchers in this week's BMJ.
The Cedars-Sinai Regenerative Medicine Institute has received a $2.5 million grant from the Department of Defense to conduct animal studies that, if successful, could provide the basis for a clinical trial of a gene therapy product for patients with Lou Gehrig's disease, also called amyotrophic lateral sclerosis, or ALS.
› Verified 7 days ago
| Entity Name | Beacon Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033161617 PECOS PAC ID: 1254243306 Enrollment ID: O20031105000657 |
News Archive
The changing tide of Alzheimer's diagnosis presents new challenges to the public, physicians and lawmakers: if you could find out your Alzheimer's risk, would you want to know? How should doctors tell you your risk? And what does it mean for the many newly diagnosed Americans still in the workplace?
Cubist Pharmaceuticals, Inc. and Adolor Corporation today announced that they have signed a definitive agreement under which Cubist will acquire all of the outstanding shares of Adolor for $4.25 per share in cash, or approximately $190 million on a fully-diluted basis, net of Adolor's third quarter 2011 cash balance.
Women with recurrent miscarriage and infertility are undergoing tests and treatments that have no scientific rationale and are linked with known risks to mother and fetus, warn researchers in this week's BMJ.
The Cedars-Sinai Regenerative Medicine Institute has received a $2.5 million grant from the Department of Defense to conduct animal studies that, if successful, could provide the basis for a clinical trial of a gene therapy product for patients with Lou Gehrig's disease, also called amyotrophic lateral sclerosis, or ALS.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dyllan Tiburzi, 3245 Health Dr Ste 100, Granger, IN 46530-1380 Ph: (574) 647-2129 | Dyllan Tiburzi, 2235 Cleveland Rd, South Bend, IN 46628-3529 Ph: (574) 647-4530 |
News Archive
The changing tide of Alzheimer's diagnosis presents new challenges to the public, physicians and lawmakers: if you could find out your Alzheimer's risk, would you want to know? How should doctors tell you your risk? And what does it mean for the many newly diagnosed Americans still in the workplace?
Cubist Pharmaceuticals, Inc. and Adolor Corporation today announced that they have signed a definitive agreement under which Cubist will acquire all of the outstanding shares of Adolor for $4.25 per share in cash, or approximately $190 million on a fully-diluted basis, net of Adolor's third quarter 2011 cash balance.
Women with recurrent miscarriage and infertility are undergoing tests and treatments that have no scientific rationale and are linked with known risks to mother and fetus, warn researchers in this week's BMJ.
The Cedars-Sinai Regenerative Medicine Institute has received a $2.5 million grant from the Department of Defense to conduct animal studies that, if successful, could provide the basis for a clinical trial of a gene therapy product for patients with Lou Gehrig's disease, also called amyotrophic lateral sclerosis, or ALS.
› Verified 7 days ago
Dr. Jon Andrew Shull, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1708 High St, South Bend, IN 46613 Phone: 574-647-1400 Fax: 574-237-6663 | |
Louis Cavadini, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 211 N Eddy St, South Bend, IN 46617 Phone: 574-237-9395 Fax: 574-204-6345 | |
Dale Alan Patterson, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 714 N Michigan St, South Bend, IN 46601 Phone: 574-647-7477 | |
Dr. Nicholas Harold Kerr, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 615 N Michigan St, 1st Fl Hospitalist Ste, South Bend, IN 46601 Phone: 574-647-3050 Fax: 574-647-1094 | |
Dr. Curtis L Gongwer, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4440 North Portage Avenue, South Bend, IN 46628 Phone: 574-204-6200 Fax: 574-288-1426 | |
Robert Hays, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 17321 State Road 23, South Bend, IN 46635 Phone: 574-335-8400 Fax: 574-335-0796 | |
Matthew T. Dupre, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 714 N Michigan St, South Bend, IN 46601 Phone: 574-647-7477 Fax: 574-647-3655 |